Suppr超能文献

接受体外膜肺氧合治疗的儿科心脏重症监护病房患者的死亡风险因素。

Risk factors for mortality in paediatric cardiac ICU patients managed with extracorporeal membrane oxygenation.

作者信息

Achuff Barbara-Jo, Elias Matthew D, Ittenbach Richard F, Ravishankar Chitra, Nicolson Susan C, Spray Thomas L, Fuller Stephanie, Gaynor J William, O'Connor Matthew J

机构信息

1Division of Critical Care,Texas Children's Hospital,Houston,TX,USA.

2Divisions of Cardiology,The Children's Hospital of Philadelphia,Philadelphia,PA,USA.

出版信息

Cardiol Young. 2019 Jan;29(1):40-47. doi: 10.1017/S1047951118001774. Epub 2018 Oct 31.

Abstract

BACKGROUND

Veno-arterial extracorporeal membrane oxygenation is frequently used in patients with cardiac disease. We evaluated short-term outcomes and identified factors associated with hospital mortality in cardiac patients supported with veno-arterial extracorporeal membrane oxygenation.

METHODS

A retrospective review of patients supported with veno-arterial extracorporeal membrane oxygenation at a university-affiliated children's hospital was performed.

RESULTS

A total of 253 patients with cardiac disease managed with extracorporeal membrane oxygenation were identified; survival to discharge was 48%, which significantly improved from 39% in an earlier era (1995-2001) (p=0.01). Patients were categorised into surgical versus non-surgical groups on the basis of whether they had undergone cardiac surgery before or not, respectively. The most common indication for extracorporeal membrane oxygenation was extracorporeal cardiopulmonary resuscitation: 96 (51%) in the surgical group and 45 (68%) in the non-surgical group. In a multiple covariate analysis, single-ventricle physiology (p=0.01), duration of extracorporeal membrane oxygenation (p<0.01), and length of hospital stay (p=0.03) were associated with hospital mortality. Weekend or night shift cannulation was associated with mortality in non-surgical patients (p=0.05).

CONCLUSION

We report improvement in survival compared with an earlier era in cardiac patients supported with extracorporeal membrane oxygenation. Single-ventricle physiology continues to negatively impact survival, along with evidence of organ dysfunction during extracorporeal membrane oxygenation, duration of extracorporeal membrane oxygenation, and length of stay.

摘要

背景

静脉-动脉体外膜肺氧合常用于心脏病患者。我们评估了接受静脉-动脉体外膜肺氧合支持的心脏病患者的短期结局,并确定了与医院死亡率相关的因素。

方法

对一所大学附属医院接受静脉-动脉体外膜肺氧合支持的患者进行回顾性研究。

结果

共确定了253例接受体外膜肺氧合治疗的心脏病患者;出院生存率为48%,较早期(1995 - 2001年)的39%有显著提高(p = 0.01)。根据患者是否曾接受心脏手术,将其分为手术组和非手术组。体外膜肺氧合最常见的适应证是体外心肺复苏:手术组96例(51%),非手术组45例(68%)。在多变量分析中,单心室生理状态(p = 0.01)、体外膜肺氧合持续时间(p < 0.01)和住院时间(p = 0.03)与医院死亡率相关。周末或夜班插管与非手术患者的死亡率相关(p = 0.05)。

结论

我们报告称,与早期相比,接受体外膜肺氧合支持的心脏病患者的生存率有所提高。单心室生理状态继续对生存率产生负面影响,同时有证据表明体外膜肺氧合期间存在器官功能障碍、体外膜肺氧合持续时间和住院时间也会影响生存率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验